
Mohini Ranganathan
Associate Chief · Yale-New Haven Hospital
Credentials: · · ·
History
- Present
- Present
- Present

- 1995–1999
Research
The acute effects of cannabinoids on memory in humans: a review
Review · Psychopharmacology · 2006 · First of 2 authors · 350 citations
Neuropsychopharmacology · 2008 · 213 citations
Cannabis and psychosis/schizophrenia: human studies
Review · European Archives of Psychiatry and Clinical Neuroscience · 2009 · Last of 3 authors · 183 citations
- DD
70 papers
- RR
18 papers · 8 as a resident

17 papers
- RS
16 papers
- JC
10 papers · 6 as a resident

9 papers
- TS
9 papers

8 papers · 4 as a resident
Grants
- 2019–2024
National Center for Complementary and Integrative Health · R21
PI · $512.6K · Yale University
- 2016–2022
Multimodal Imaging of Recovery from Cannabis Dependence
National Institute on Drug Abuse · R01
PI · $2.9M · Yale University
- 2015–2018
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
National Institute on Drug Abuse · R21
Contact PI · $358K · Yale University
- 2011–2014
Cannabidiol Modulation of ???-9-THC???s Psychotomimetic Effects in Healthy Humans
National Institute on Drug Abuse · R21
Contact PI · $360K · Yale University
Clinical trials
- 2021–2024
- 2020–2021
FAAH Availability in Psychiatric Disorders: A PET Study
Principal investigator · Terminated · Early phase 1
Yale University
- 2020–2023
- 2018–2026
CB1R in Synthetic Psychoactive Cannabinoids
Principal investigator · Active not recruiting
Yale University
